hims compounded semaglutide review and Wegovy: Branded vs Introducing compounded GLP-1 injections from

Implications for employers: Many of those who stop GLP-1 medications do so because they do not have coverage and cannot afford to continue

Is the patient protecting muscle as weight decreases

If patients stop retatrutide, weight returns

The most commonly reported side effects were gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, which were generally mild to moderate and occurred mainly during dose escalation

These may include symptoms such as nausea, changes in bowel habits, or reduced appetite, particularly during early treatment phases or following dose adjustments

As patients lose weight and improve glycemic control, alterations in insulin sensitivity, leptin levels, and other metabolic hormones could potentially affect taste perception